The weekly litigation news digest is live. Subscribe now

IP Verse

Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus - EP3086782

The patent EP3086782 was granted to DR Falk Pharma on Sep 26, 2018. The application was filed on Dec 18, 2014 under application number EP14814872A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3086782

DR FALK PHARMA
Application Number
EP14814872A
Filing Date
Dec 18, 2014
Status
Opposition Rejected
Aug 19, 2022
Publication Date
Sep 26, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ELLODI PHARMACEUTICALSJun 26, 2019COOLEY UKADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2151235
OPPOSITIONUS2007020330
OPPOSITIONUS2010034894
OPPOSITIONUS2011123460

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents